Abnormal hormone levels in men with coronary artery disease

B. Zumoff, R. G. Troxler, J. O'Connor, R. S. Rosenfeld, J. Kream, J. Levin, J. R. Hickman, A. M. Sloan, W. Walker, R. L. Cook, D. K. Fukushima

Research output: Contribution to journalArticlepeer-review

68 Scopus citations


Plasma concentrations and urinary excretions of various hormones and hormone metabolites were measured in four groups. Group 1 was composed of 13 men with prior myocardial infarction; Group 2 contained 35 clinically normal men; Group 3 consisted of 44 men with normal coronary arteriograms; and Group 4 was composed of 25 men with severe coronary artery disease shown on arteriogram but no infarction. There were four major findings: Group 1 had significantly higher 24-hour mean plasma concentrations of estrone (E1), dehydroisoandrosterone (DHA), and dehydroisoandrosterone sulfate (DHAS) than Group 2, while Group 3 had the same levels as Group 4; Group 4 had significantly lower urinary excretion of androsterone glucuronide (AG) than Group 3, while Group 1 excreted normal amounts. There are three possible explanations for these findings: myocardial infarction occurring in men with coronary artery disease may elevate the plasma levels of E1, DHA, and DHAS and eliminate the preinfarction depression of urinary AG levels; higher than average levels of E1, DHA, DHAS, and AG may favor the development of infarction in men with coronary artery disease; higher than average levels of E1, DHA, DHAS, and AG may favor survival from any infarction that occurs in men with coronary artery disease. Experimental and epidemiological evidence seems to favor the third possibility.

Original languageEnglish (US)
Pages (from-to)58-67
Number of pages10
JournalUnknown Journal
Issue number1
StatePublished - 1982
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Abnormal hormone levels in men with coronary artery disease'. Together they form a unique fingerprint.

Cite this